Boston scientific announces agreement to acquire relievant medsystems, inc.

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain marlborough, mass. , sept. 19, 2023 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced it has entered into a definitive agreement to acquire relievant medsystems, inc., a privately held medical technology company that has developed and commercialized the intracept® intraosseous nerve ablation system to treat vertebrogenic pain, a form of chronic low back pain.
BSX Ratings Summary
BSX Quant Ranking